1型糖尿病诊断时糖尿病酮症酸中毒与糖尿病技术使用及随访1年和2年后临床结局的关联:一项涉及九国9269名1型糖尿病儿童的小儿登记协作分析
该协作分析纳入九国9269名2019-2020年诊断为1型糖尿病的0.5-15.9岁青少年,随访2年。诊断时34.2%存在糖尿病酮症酸中毒(DKA),12.8%为重度DKA。重度DKA组随访1年调整后平均HbA1c为7.41%,高于非重度DKA组7.23%(P=0.001)和无DKA组7.14%(P<0.001);2年后差异持续(7.58% vs 7.38% [P<0.001] 和 vs 7.32% [P<0.001])。使用自动胰岛素输注(AID)与较低HbA1c相关,并减弱DKA与较高HbA1c的关联(P=0.072)。
要点
- 诊断时重度DKA组随访1年调整后平均HbA1c为7.41%,高于非重度DKA组7.23%和无DKA组7.14%。
- 诊断时DKA与随访2年持续较高HbA1c及较高BMI SDS相关。
- AID使用与较低HbA1c相关,并减弱DKA与较高HbA1c的关联(P=0.072)。
主要发现
- 诊断时DKA占34.2%,重度DKA占12.8%;纳入9269人,男性54.8%,平均年龄9.0岁。
- 随访1年调整后平均HbA1c重度DKA组7.41%,高于非重度DKA组7.23%(P=0.001)和无DKA组7.14%(P<0.001)。
- 随访2年调整后平均HbA1c重度DKA组7.58%,高于非重度DKA组7.38%(P<0.001)和无DKA组7.32%(P<0.001)。
- 两个DKA组BMI SDS均高于无DKA组。
- AID使用与较低HbA1c相关,并减弱DKA组间差异(P=0.072)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study examined the association between diabetic ketoacidosis (DKA) at type 1 diabetes diagnosis and long-term glycemic outcomes, insulin requirements, BMI SD score (SDS), and diabetes technology uptake in youth. RESEARCH DESIGN AND METHODS: Data were from nine countries (Austria, Czechia, Germany, Italy, Luxembourg, New Zealand, Slovenia, Switzerland, and U.S. [Colorado]), including youth (0.5-15.9 years) diagnosed with type 1 diabetes in 2019-2020 and followed for 2 years thereafter. Participants were divided into three groups: no DKA, nonsevere, and severe DKA at diagnosis. HbA1c, insulin requirements, BMI SDS, and use of technology, including automated insulin delivery (AID), were assessed. RESULTS: The analysis included 9,269 individuals (54.8% males, mean age 9.0 years). DKA at diagnosis was observed in 34.2% of participants and severe DKA in 12.8%. After 1 year, adjusted mean HbA1c was higher in the severe DKA group (7.41%) compared with nonsevere DKA (7.23%, P = 0.001) and no DKA groups (7.14, P < 0.001), and this difference persisted after 2 years (7.58% vs. 7.38% [P < 0.001] and vs. 7.32% [P < 0.001]). Higher BMI SDS was observed in both DKA groups compared with no DKA. The use of AID was associated with lower HbA1c levels compared with other treatment modalities and moderated differences between DKA groups after 2 years of follow-up (P = 0.072). CONCLUSIONS: Severe and nonsevere DKA at type 1 diabetes diagnosis were both associated with persistently higher HbA1c and higher BMI SDS. AID use diminishes the association of DKA at diagnosis and higher HbA1c over time.
引用
- Dovc K, Neuman V, Gita G, et al. Association of Diabetic Ketoacidosis at Onset, Diabetes Technology Uptake, and Clinical Outcomes After 1 and 2 Years of Follow-up: A Collaborative Analysis of Pediatric Registries Involving 9,269 Children With Type 1 Diabetes From Nine Countries. Diabetes Care. 2025. PMID: 39965057. doi:10.2337/dc24-2483
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。